Newsfiscal.ai
Lexaria Bioscience Enters New Pharmaceutical Agreement for DehydraTECH
· Published
Article summary
Lexaria Bioscience Corp. has signed an agreement with an unnamed pharmaceutical company to evaluate its proprietary DehydraTECH drug delivery technology with the partner's molecules.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…